Company: PGEN
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001356090-25-000034
Chunk: 26

Company: PRECIGEN, INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 26
---
4— $— 252,656,151 $— 3,742,376 $— $2,093,080 $(2,909)$(2,047,001)$43,170 Stock-based compensation— — — — — — 2,061 — — 2,061 Shares issued upon vesting of restricted stock units and for exercises of stock options— — 316,402 — (316,402)— 294 — — 294 Shares issued as payment for services— — 17,605 — (17,605)— 25 — — 25 Shares issued in public offerings, net of issuance costs39,878,939 — (3,408,369)— 30,882 — — 30,882 Net loss— — — — — — — — (23,978)(23,978)Release of cumulative translation adjustments to other income (expense), net— — — — — 2,915 — 2,915 Other comprehensive income— — — — — — — 7 — 7 Balances at September 30, 2024— $— 292,869,097 $— — $— $2,126,342 $13 $(2,070,979)$55,376 

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

Precigen, Inc. and Subsidiaries

Condensed Consolidated Statements of Mezzanine Equity and Shareholders' Equity

(Unaudited)

Mezzanine EquityShareholders' Equity(Amounts in thousands, except share data)Preferred StockCommon StockAdditionalPaid-inCapitalAccumulatedOtherComprehensiveIncome (Loss)AccumulatedDeficitTotalShareholders'EquitySharesAmountSharesAmountBalances at December 31, 202479,000 $28,218 292,869,097 $— $2,129,207 $12 $(2,090,706)$38,513 Stock-based compensation— — — — 8,814 — — 8,814 Shares issued upon vesting of restricted stock units, performance stock units and for exercises of stock options— — 3,409,769